A Phase 1 Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644) and Core-g28v2 60mer mRNA Vaccine (mRNA-1644v2-Core)

We are looking for healthy volunteers to participate in an investigational HIV vaccine study. The purpose of the study is to see if the vaccine is safe and produces a good immune response.

More information regarding the study can be found: https://clinicaltrials.gov/ct2/show/NCT05001373


International AIDS Vaccine Initiative
Principal Investigator(s)
Dr. David Diemert, MD/Medicine & Microbiology, Immunology and Tropical Medicine
Contact Phone Number